iSpecimen Inc. Files 8-K: Regulation FD Disclosure & Exhibits
Ticker: ISPC · Form: 8-K · Filed: Aug 21, 2025 · CIK: 1558569
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
iSpecimen filed an 8-K on 8/21/25 for Reg FD disclosure and exhibits. Details TBD.
AI Summary
On August 21, 2025, iSpecimen Inc. filed a Form 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details of the disclosure at this time.
Why It Matters
This filing indicates that iSpecimen Inc. is making a disclosure under Regulation FD and providing financial statements and exhibits, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural update and does not contain specific negative or positive financial news.
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- August 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40501 (commission_file_number) — SEC File Number
- 27-0480143 (ein) — IRS Employer Identification No.
- 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal executive offices
- 781-301-6700 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that it is being made.
What financial statements and exhibits are included in this filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was the earliest event reported in this Form 8-K?
The earliest event reported is August 21, 2025.
What is the principal executive office address for iSpecimen Inc.?
The principal executive office is located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.
What is the SEC file number for iSpecimen Inc.?
The SEC file number for iSpecimen Inc. is 001-40501.
Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-08-21 08:00:35
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ISPC The Nasdaq Stock Mar
Filing Documents
- ea0253946-8k_ispecimen.htm (8-K) — 25KB
- ea025394601ex99-1_ispecimen.htm (EX-99.1) — 12KB
- 0001213900-25-079167.txt ( ) — 204KB
- ispc-20250821.xsd (EX-101.SCH) — 3KB
- ispc-20250821_lab.xml (EX-101.LAB) — 33KB
- ispc-20250821_pre.xml (EX-101.PRE) — 22KB
- ea0253946-8k_ispecimen_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 21, 2025, iSpecimen Inc. (the "Company") issued a press release announcing the successful completion of Milestone 1 in its digital transformation program powered by Salestack Solutions. This achievement marks the installation of the new Salestack platform and provisioning of modern infrastructure. The Company is now positioned to advance to Milestone 2 (Integration), which will focus on connecting all parts of the Company's business to the Salestack platform to create end-to-end efficiency across operations, customer engagement, and data management. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated August 21, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 21, 2025 iSPECIMEN INC. By: /s/ Robert Bradley Lim Name: Robert Bradley Lim Title: Chief Executive Officer 2